BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6697402)

  • 1. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 2. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
    Dostal T; Kabes J
    Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
    Ivanov V; Popov G
    Agressologie; 1981 Nov; 22(D):29-30. PubMed ID: 7332038
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
    Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    Levin A
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maprotiline in pain-depression.
    Lindsay PG; Olsen RB
    J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomifensine: the preclinical and clinical profile of a second generation antidepressant.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):1-105. PubMed ID: 6370968
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
    Guliamov MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):582-7. PubMed ID: 3716711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
    Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
    Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with maprotiline.
    Kabes J; Dostal T; Roth Z
    Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical considerations regarding the use of maprotiline in psychiatric treatment].
    Pirozynski T; Chiriţă V; Mungiu OC; Cosmovici N; Boişteanu P
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):251-5. PubMed ID: 3685686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the clinical trial with nomifensine (author's transl)].
    Kabes J; Balon R; Papezová H
    Cesk Psychiatr; 1981 Feb; 77(1):42-9. PubMed ID: 7018711
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
    Act Nerv Super (Praha); 1982 May; 24(2):39-118. PubMed ID: 7102224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.